NanoViricides, Inc. NEW (NNVC): Price and Financial Metrics


NanoViricides, Inc. NEW (NNVC): $1.43

0.04 (+2.58%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NNVC to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

NNVC Stock Price Chart Interactive Chart >

Price chart for NNVC

NNVC Price/Volume Stats

Current price $1.43 52-week high $3.88
Prev. close $1.39 52-week low $1.04
Day low $1.36 Volume 10,828
Day high $1.44 Avg. volume 20,343
50-day MA $1.40 Dividend yield N/A
200-day MA $1.80 Market Cap 16.55M

NanoViricides, Inc. NEW (NNVC) Company Bio


NanoViricides, Inc. is a biopharmaceutical company. The Company researches treatments for viruses such as AIDS/HIV, Hepatitis C, influenza, and Asian bird flu.


NNVC Latest News Stream


Event/Time News Detail
Loading, please wait...

NNVC Latest Social Stream


Loading social stream, please wait...

View Full NNVC Social Stream

Latest NNVC News From Around the Web

Below are the latest news stories about NANOVIRICIDES INC that investors may wish to consider to help them evaluate NNVC as an investment opportunity.

NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT

NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk in person at the Biotech Showcase™ 2023 Conference in San Fransisco on Monday, January 9th at 10:30pm PT.

Yahoo | January 4, 2023

NanoViricides, Inc. to Present at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ET

NanoViricides, Inc. (NYSE Amer. NNVC) (the "Company"), announces that the Company's President, Dr. Anil Diwan, will be presenting a talk at the RHK Capital Disruptive Growth Conference in New York City on December 6th at 1:20pm ET.

Yahoo | December 5, 2022

NanoViricides, Inc. Has Filed its Quarterly Report: Coronavirus Drug NV-CoV-2 IND Stage

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending September 30, 2022 with the Securities and Exchange Commission (SEC) on Monday, November 14, 2022.

Yahoo | November 15, 2022

7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.

Speculative penny stocks don't look as volatile now that volatility is unavoidable.

Alex Sirois on InvestorPlace | October 28, 2022

This Company Is Looking For A Monkeypox Drug As City Investigates Deaths

By David Willey, Benzinga

Yahoo | October 27, 2022

Read More 'NNVC' Stories Here

NNVC Price Returns

1-mo 6.72%
3-mo -13.60%
6-mo -53.57%
1-year -40.91%
3-year -79.42%
5-year -92.92%
YTD 28.83%
2022 -70.16%
2021 29.62%
2020 14.34%
2019 -37.25%
2018 -77.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6784 seconds.